About ReactorMD
Computational drug discovery services built around careful preparation, reproducible simulation and honest reporting.
Founder & Scientific Background
Sohel Akhtar Ansari is the founder of ReactorMD and a computational drug discovery researcher. His research focuses on computational antitubercular drug discovery, molecular docking, molecular dynamics simulations, ligand preparation, molecular modelling, 2D QSAR, virtual screening, and scientific data analysis.
ReactorMD grew directly from hands-on experience preparing receptor and ligand structures, executing explicit-solvent GROMACS molecular dynamics workflows, performing trajectory post-processing, and assembling transparent scientific reports.
Why ReactorMD exists
Many students and small labs need docking and molecular dynamics but lack GPU time, software setup or experience with GROMACS. ReactorMD packages a careful, documented workflow so that the work is done properly and the results arrive in a form that can be used in a thesis or a paper.
How we work
- Prepare carefully. Structures and ligands are checked and prepared before any calculation.
- Compute reproducibly. Settings, versions and inputs are recorded and returned to you.
- State the limits. Every report says what the method can and cannot show.
- Price openly. Prices are visible before you start, and extra charges need your approval.
What ReactorMD is not
ReactorMD provides computational research tools. Results are predictions and are not experimental confirmation or clinical advice.
Talk to us
Questions, custom scope or publication requirements? Send a message.